Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for bepridil (compound)


PubChem
Name: Bepridil
PubChem Compound ID: 2351
Description: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
Molecular formula: C24H34N2O
Molecular weight: 366.54 g/mol
Synonyms:
C06847; NINDS_000110; Bio2_000501; 68099-86-5; KBio1_000110; Spectrum4_000797; Spectrum_001745; Bio1_000388; Bepridil; KBio2_004793.
show more »
DrugBank
Identification
Name: Bepridil
Name (isomeric): DB01244
Drug Type: small molecule
Description: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
Synonyms:
Bepadin
Brand: Vascor
Category: Vasodilator Agents, Antiarrhythmic Agents, Calcium Channel Blockers, Anti-Arrhythmia Agents, Antihypertensive Agents
CAS number: 64706-54-3
Pharmacology
Indication: For the treatment of chronic stable angina (classic effort-associated angina).
Pharmacology: Bepridil is a calcium channel blocker that has well characterized anti-anginal properties and known but poorly characterized type 1 anti-arrhythmic and anti-hypertensive properties. It is not related chemically to other calcium channel blockers such as diltiazem hydrochloride, nifedipine and verapamil hydrochloride.
Mechanism of Action:
Bepridil has inhibitory effects on both the slow calcium (L-type) and fast sodium inward currents in myocardial and vascular smooth muscle, interferes with calcium binding to calmodulin, and blocks both voltage and receptor operated calcium channels. Bepridil inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle....
show more »
Absorption: Rapidly and completely absorbed after oral administration.
Protein binding: 99%
Biotransformation: Hepatic.
Half Life: 24-50 hours
Toxicity: There has been one experience with overdosage in which a patient inadvertently took a single dose of 1600 mg of bepridil. The patient was observed for 72 hours in intensive care, but no significant adverse experiences were noted.
Affected organisms: Humans and other mammals
Interactions
Food interaction:
Take with food to reduce nausea.
Drug interaction:
GrepafloxacinIncreased risk of cardiotoxicity and arrhythmias
LevofloxacinIncreased risk of cardiotoxicity and arrhythmias
RitonavirRitonavir increases the effect and toxicity of bepridil
SparfloxacinIncreased risk of cardiotoxicity and arrhythmias
TerfenadineIncreased risk of cardiotoxicity and arrhythmias
show more »

Targets


Enzymes


Transporters